Cargando…
miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
Bromodomain Containing 4 (BRD4) mediates transcriptional elongation of the oncogene MYC by binding to acetylated histones. BRD4 has been shown to play a critical role in tumorigenesis in several cancers, and the BRD4-NUT fusion gene is a driver of NUT midline carcinoma (NMC), a rare but highly letha...
Autores principales: | Tonouchi, Erina, Gen, Yasuyuki, Muramatsu, Tomoki, Hiramoto, Hidekazu, Tanimoto, Kousuke, Inoue, Jun, Inazawa, Johji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852021/ https://www.ncbi.nlm.nih.gov/pubmed/29540837 http://dx.doi.org/10.1038/s41598-018-22767-y |
Ejemplares similares
-
Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018) -
Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells
por: Liu, Chang, et al.
Publicado: (2021) -
The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns
por: Zee, Barry M., et al.
Publicado: (2016) -
Supercharging BRD4 with NUT in carcinoma
por: Eagen, Kyle P., et al.
Publicado: (2021) -
Molecular features driving condensate formation and gene expression by the BRD4-NUT fusion oncoprotein are overlapping but distinct
por: Kosno, Martyna, et al.
Publicado: (2023)